WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001087915) A NOVEL PEPTIDE---HUMAN GM2 ACTIVIATION PROTEIN 14 AND THE POLYNUCLEOTIDE CODING THIS NOVEL PEPTIDE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/087915    International Application No.:    PCT/CN2001/000228
Publication Date: 22.11.2001 International Filing Date: 26.02.2001
IPC:
C07K 14/47 (2006.01)
Applicants: BIOWINDOW GENE DEVELOPMENT INC. SHANGHAI [CN/CN]; 12F, 3rd Building No. 1111 Zhongshan Bei Er Rd Shanghai 200092 (CN) (For All Designated States Except US).
MAO, Yumin [CN/CN]; (CN) (For US Only).
XIE, Yi [CN/CN]; (CN) (For US Only)
Inventors: MAO, Yumin; (CN).
XIE, Yi; (CN)
Agent: WATSON & BAND LAW OFFICES; 61 Nanjing Rd (E) 11th Floor Shanghai 200002 (CN)
Priority Data:
00 1 11833.1 02.03.2000 CN
Title (EN) A NOVEL PEPTIDE---HUMAN GM2 ACTIVIATION PROTEIN 14 AND THE POLYNUCLEOTIDE CODING THIS NOVEL PEPTIDE
(FR) NOUVEAU POLYPEPTIDE, PROTEINE HUMAINE D'ACTIVATION 14 DE GM2, ET POLYNUCLEOTIDE CODANT POUR CE POLYPEPTIDE
Abstract: front page image
(EN)The invention discloses a novel peptide--- human GM2 activation protein 14, polynucleotide coding this peptide and the method producing this peptide by DNA recombination techniques. This invention also discloses the therapeutical mehods with this peptide for several diseases, such as family cretinism, nervous system illness, some tumor, fetation maladjusted illness, develop and growth impedient illness, inflammation immunological illness, haemal illness, HIV infection et al. This invention also discloses an antagonist against this peptide and its therapeutical effect. The invention also discloses the use of this polynucleotide coding the novel human GM2 activation protein 14.
(FR)L'invention concerne un nouveau polypeptide, une protéine humaine d'activation 14 de GM2, et un polynucléotide codant pour ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment de l'idiotie amaurotique familiale, des troubles du système nerveux, de certaines tumeurs, des troubles du développement de l'embryon, des troubles du développement et de la croissance, des inflammations, des maladies immunitaires, de l'hémopathie et de l'infection par VIH. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour la protéine humaine d'activation 14 de GM2.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)